When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
INCY - FDA OKs Incyte's pemigatinib for type of bile duct cancer
Incyte Corporation
The FDA approves Incyte's (NASDAQ:INCY) Pemazyre (pemigatinib) for the treatment of adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma (cancer of the bile ducts) with an FGFR2 fusion or other rearrangement as detected by an FDA-approved test.
More news on: Incyte Corporation, Healthcare stocks news,